Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment
✍ Scribed by Damber, J. -E. ;Bergh, A. ;Assarsson, B. ;G�fvels, M.
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 703 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
BACKGROUND. Epidermal growth factor (EGF) induces proliferation in prostate epithelial and stromal cells in primary culture. This investigation was set up to characterize the time and spatial expression of EGF in the rat prostate. METHODS. The expression of EGF was characterized in the distinct lobe
The effects of androgen manipulation on epidermal growth factor (EGF) receptor, p185 erbB-2 and transforming growth factor-␣ (TGF-␣) levels were examined in prostatic adenocarcinoma. Male nude mice were inoculated with the CWR22 androgen-dependent human prostatic tumor or an androgenindependent (CWR
In the aged liver, cell proliferation and induction of DNA synthesis by epidermal growth factor is impaired. Changes in the hepatic handling of epidermal growth factor may be important for these effects. I compared epidermal growth factor handling in the livers of young and old rats. Epidermal growt